Post-earnings recap
Reported
Wed, Jan 25, 2023
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Abbott Laboratories reported better-than-expected earnings per share, beating estimates by 14.32%. However, the stock reacted negatively, declining by 1.36%. The lack of revenue data and guidance may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.03 | N/A | +14.32% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—